XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Statement of Cash Flows [Abstract]            
Revenues $ 54 $ 2,316 $ 1,660 $ 2,316 $ 6,964 $ 23,703
Operating Expenses:            
Cost of revenues 150 297 150 1,283 3,530
Advertising (4,578) 43,020 18,125 43,020 58,961 29,764
Payroll and related expense 66,693 63,879 225,603 239,770 303,850 1,156,914
Stock-based compensation         222,700
Amortization of software costs         38,549
Impairment of software costs         196,315
Allowance for uncollectible advances to COWA Science Corporation (“COWA”)         360,500
Other general and administrative expenses 333,197 101,189 953,927 413,417 803,081 1,460,867
Total Operating Expenses 395,312 208,238 1,197,952 696,357 1,167,175 3,469,139
Loss From Operations (395,258) (205,922) (1,196,292) (694,041) (1,160,211) (3,445,436)
Other Income (Expense):            
Interest expense (1,191,405) (1,602,204) (2,159,564) (3,607,210) (5,139,321) (4,935,470)
Preferred stock issuance costs         (5,585,594)
Change in derivative liability for authorized shares shortfall 2,641,481 66,572,635 (159,633,797) (43,406,183) (170,319,590) (18,921,537)
Change in fair value of derivative liabilities (85,287) 300,885 303,593 (451,351) (685,415)
Impairment on investment         (91,931)
Gain on forgiveness of debt 192,521 250,000
Gain (loss) on settlement of convertible notes payable and accrued interest, warrants and accounts payable and cancelation of common shares in exchange for Series Y and Series Z preferred shares and cash (1,578,559) 173,361,276 162,109,131
Gain (loss) on conversion of convertible notes (880) 882 882 (603,529)
Total Other Income (Expense) (128,483) 64,885,144 12,060,441 (46,708,918) (13,550,249) (30,823,476)
Net Income (Loss) Before Income Taxes (523,741) 64,679,222 10,864,149 (47,402,959) (14,710,460) (34,268,912)
Provision for Income Taxes (Benefit)
Net Income (Loss) (523,741) 64,679,222 10,864,149 (47,402,959) (14,710,460) (34,268,912)
Deemed dividend from warrant price protection (95,002,933) (95,838,488) (28,933,472)
Deemed dividend resulting from amortization of preferred stock discount (34,798,923) (1,074,539)
Contingent beneficial conversion feature on preferred shares issuance         (45,147,093)
Deemed dividend for issuance of common shares to settle warrant provision         (437,400)
Deemed dividend from exchange of preferred shares for convertible notes         (1,476,280)
Net Income (Loss) Available to Common Stockholders $ (523,741) $ 64,679,222 $ (23,934,774) $ (142,405,892) $ (111,623,487) $ (110,263,157)
Net loss per common share:            
Basic (in Dollars per share) $ 0.05 $ (0.02) $ (0.1) $ (0.08) $ (0.19)
Diluted (in Dollars per share) $ (0.02) $ (0.1) $ (0.08) $ (0.19)
Weighted average common shares outstanding:            
Basic (in Shares) 1,406,244,901 1,401,226,219 1,405,511,082 1,387,478,585 1,390,934,274 576,802,421
Diluted (in Shares) 1,406,244,901 40,198,748,273 1,405,511,082 1,387,478,585 1,390,934,274 576,802,421